N-isopropylpyridazin-3-aMine
![]() |
- $65 - $1500
- Product name: N-isopropylpyridazin-3-aMine
- CAS: 1248509-73-0
- MF: C7H11N3
- MW: 137.18
- EINECS:
- MDL Number:MFCD16767557
- Synonyms:N-isopropylpyridazin-3-aMine;3-Pyridazinamine, N-(1-methylethyl)-
5 prices
Selected condition:
Brand
- Alichem
- Crysdot
- Matrix Scientific
- TRC
Package
- 5mg
- 50mg
- 250mg
- 1g
- ManufacturerAlichem
- Product number1248509730
- Product descriptionN-Isopropylpyridazin-3-amine
- Packaging250mg
- Price$577.8
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11316389
- Product descriptionN-Isopropylpyridazin-3-amine 95+%
- Packaging1g
- Price$1480
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number189211
- Product descriptionN-Isopropylpyridazin-3-amine
- Packaging1g
- Price$1500
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberN489173
- Product descriptionN-isopropylpyridazin-3-amine
- Packaging50mg
- Price$330
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberN489173
- Product descriptionN-isopropylpyridazin-3-amine
- Packaging5mg
- Price$65
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Alichem | 1248509730 | N-Isopropylpyridazin-3-amine | 250mg | $577.8 | 2021-12-16 | Buy |
Crysdot | CD11316389 | N-Isopropylpyridazin-3-amine 95+% | 1g | $1480 | 2021-12-16 | Buy |
Matrix Scientific | 189211 | N-Isopropylpyridazin-3-amine | 1g | $1500 | 2021-12-16 | Buy |
TRC | N489173 | N-isopropylpyridazin-3-amine | 50mg | $330 | 2021-12-16 | Buy |
TRC | N489173 | N-isopropylpyridazin-3-amine | 5mg | $65 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): |
![]() ![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | |||||||||||||||||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Precautionary statements: |
|